Effects of Spironolactone on Serum Markers of Fibrosis in People at High Risk of Developing Heart Failure: Rationale, Design and Baseline Characteristics of a Proof‐Of‐Concept, Randomised, Precision‐Medicine, Prevention Trial. The Heart Omics in Aging (Homage) Trial
AuthID
P-00V-8NH
P-00V-8NH